Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration‐sensitive prostate cancer: A multicenter retrospective study

Author:

Hatakeyama Shingo1,Narita Shintaro2,Takahashi Masahiro3,Sakurai Toshihiko4,Kawamura Sadafumi5,Hoshi Senji6,Ishida Masanori7,Kawaguchi Toshiaki8,Ishidoya Shigeto9,Shimoda Jiro7,Sato Hiromi2,Hamano Itsuto1,Okamoto Teppei1,Mitsuzuka Koji3,Ito Akihiro3,Tsuchiya Norihiko4,Arai Yoichi5,Habuchi Tomonori2,Ohyama Chikara1

Affiliation:

1. Department of Urology Hirosaki University School of Medicine Hirosaki Japan

2. Department of Urology Akita University School of Medicine Akita Japan

3. Department of Urology Tohoku University School of Medicine Sendai Japan

4. Department of Urology Yamagata University School of Medicine Yamagata Japan

5. Department of Urology Miyagi Cancer Center Natori Japan

6. Department of Urology Yamagata Prefectural Central Hospital Yamagata Japan

7. Department of Urology Iwate Prefectural Isawa Hospital Isawa Japan

8. Department of Urology Aomori Prefectural Central Hospital Aomori Japan

9. Department of Urology Sendai City Hospital Sendai Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Urology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3